Vaccine Development

Oct 21, 2016
By BioPharm International Editors
Insulin has been shown to improve the production of viruses and viral vectors.
Oct 14, 2016
By BioPharm International Editors
The companies will collaborate on the manufacture of personalized cancer vaccines.
Oct 11, 2016
By BioPharm International Editors
HHS entered into a contract with BioProtection Systems Corp. for commercial manufacturing tests of an Ebola vaccine.
Oct 03, 2016
By BioPharm International Editors
The hospital received a five-year $5 million grant from CDC to survey for communicable diseases in children and evaluate vaccine effectiveness.
Aug 12, 2016
Zika vaccine development is hindered by technical challenges and funding shortfalls.
Jul 27, 2016
The Phase I trial will test Bavarian Nordic’s vaccine, which is manufactured using a vaccine vector based on smallpox.
Jul 25, 2016
The vaccine candidate has also won a Priority Medicines (PRIME) status from EMA.
Jul 08, 2016
By BioPharm International Editors
The company will collaborate with the Walter Reed Army Institute of Research to co-develop a Zika vaccine candidate.
Jun 28, 2016
By BioPharm International Editors
MilliporeSigma and the International Vaccine Institute in Seoul, South Korea aim to develop more robust, scalable vaccine manufacturing processes.
Jun 28, 2016
Antibodies to dengue may either confer protective immunity to the Zika virus or enhance disease severity in secondary, related infections such as Zika.
native1_300x100
lorem ipsum